Latest News about PFE
Recent news which mentions PFE
   Is Hims & Hers Health the Next Teladoc?
   
  
  
  September 11, 2024
  From Motley Fool
 
   2 Beaten-Down Stocks That Could Be Great Buys on the Dip
   
  
  
  September 11, 2024
  From Motley Fool
 
   3 High-Yield Stocks to Buy Hand Over Fist in September
   
  
  
  September 10, 2024
  From Motley Fool
 
   Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
   
  
  
  September 09, 2024
  From Benzinga
 
   Why Is Moderna Stock Trading Higher On Monday?
   
  
  
  September 09, 2024
  From Benzinga
 
   Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
   
  
  
  September 09, 2024
  From Benzinga
 
   3 No-Brainer Dividend Stocks With Yields Above 5% You Can Buy Now and Hold at Least a Decade
   
  
  
  September 09, 2024
  From Motley Fool
 
   3 No-Brainer Dividend Stocks to Buy in September
   
  
  
  September 08, 2024
  From Motley Fool
 
   Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone
   
  
  
  September 06, 2024
  From Benzinga
 
   FDA Battles Backlog of Drug Factory Inspections Since COVID-19
   
  
  
  September 06, 2024
  From Benzinga
 From Benzinga
 
   A Few Years From Now, You'll Wish You Had Bought This Undervalued Stock
   
  September 06, 2024
  Tickers 
   PFE
  
  
  From Motley Fool
 From Benzinga
 
   Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
   
  
  
  September 05, 2024
  From Benzinga
 
   Why Walgreens Boots Alliance Fell Another 22% in August
   
  
  
  September 05, 2024
  From Motley Fool
 
   Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
   
  
  
  September 04, 2024
  From Benzinga
 
   UK, Taiwan Approve Moderna's Updated COVID-19 Shot
   
  
  
  September 03, 2024
  From Benzinga
 
   Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
   
  
  
  September 03, 2024
  From Benzinga
 
   Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
   
  
  
  September 03, 2024
  From Benzinga
 
   Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
   
  
  
  September 03, 2024
  From Benzinga
 
   Why Is BridgeBio Pharma Stock Trading Higher On Friday?
   
  
  
  August 30, 2024
  From Benzinga
 
   Alnylam Pharmaceuticals Stock Falls After Detailed Vutrisiran Data For A Condition With Stiff Heart Muscles
   
  
  
  August 30, 2024
  From Benzinga
 
   2 Incredibly Cheap Growth Stocks to Buy Now
   
  
  
  August 30, 2024
  From Motley Fool
 
   2 Incredibly Cheap Healthcare Stocks to Buy Now
   
  
  
  August 30, 2024
  From Motley Fool
 From Motley Fool
 
   3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
   
  
  
  August 27, 2024
  From Motley Fool
 
   Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
   
  
  
  August 26, 2024
  From Benzinga
 
   Is Pfizer Stock Still a Buy After an Unexpected Setback?
   
  August 26, 2024
  Tickers 
   PFE
  
  
  From Motley Fool
 From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
